Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

127.78
Delayed Data
As of 4:00pm ET
 +2.18 / +1.74%
Today’s Change
117.58
Today|||52-Week Range
212.00
-24.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues41.1M47.2M89.9M74.9M
 
 
 
 
 
Cost of Goods Sold------1.8M
 
 
Depreciation And Amortization19.1M15.1M13.4M6.4M
 
 
 
 
 
 
Operating ExpensesGross Income------66.7M
 
 
General Expenses318.1M456.6M576.6M881.3M
 
 
 
 
 
Research And Development276.5M382.4M390.6M505.4M
 
 
 
 
 
Total Operating Expenses337.1M471.7M590.0M889.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-296.0M-424.6M-500.1M-814.7M
 
 
 
 
 
Extraordinary Credit0.000.000.0020.6M
 
 
Interest Expense On Debt0.001.2M800.0K--
 
 
 
Other Expenses76.0K7.4M-2.2M4.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-290.1M-410.1M-490.9M-760.7M
 
 
 
 
 
Income Taxes0.000.000.00-823.0K
 
 
Net Income-290.1M-410.1M-490.9M-761.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS84.0M85.6M90.6M100.6M
 
 
 
 
 
Shares To Calculate EPS Diluted84.0M85.6M90.6M100.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.45-$4.79-$5.42-$7.57
 
 
 
 
 
EPS Diluted-$3.45-$4.79-$5.42-$7.57